DEF — Defense
Hereditary Hemorrhagic Telanglectasia (HHT)
Lobbyists: MARK VIETH
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
68373fcd-2774-479d-b224-87ebdf29806d- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-15 17:57:43
- Income (reported)
- $10,000
- Expenses (reported)
- —
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Consultant firm
- Contact
- KATINA PIERCE
- Phone
- +1 202-484-1100
- Address
- zip:20024, city:Washington, state:DC, street:600 Maryland Avenue SW Suite 220E
Client
HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION
patient advocacy organization for individuals suffering from a rare disease
- State
- MD
- Country
- US
- Government-entity client
- false
- Effective date
- 2016-12-01
Issues lobbied + lobbyists
HCR — Health Issues
H.R. 7148, FY 2026 Consolidated Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT) and Funding for National HHT Center of Excellence Program; H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R./S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program
Lobbyists: MARK VIETH
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE